ArticleACS medicinal chemistry letters2021

Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets.

Michael Popadynec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.